A case of hepatitis C virus-associated mixed cryoglobulinemic vasculitis treated with daclatasvir and asunaprevir
-
- Takada Sayuri
- Department of Gastoroenterology, Kashiwara Municipal Hospital
-
- Uchida-Kobayashi Sawako
- Department of Hepatology, Graduate School of Medicine, Osaka City University
-
- Iida-Ueno Ayako
- Department of Hepatology, Graduate School of Medicine, Osaka City University
-
- Teranishi Yuga
- Department of Hepatology, Graduate School of Medicine, Osaka City University
-
- Motoyama Hiroyuki
- Department of Hepatology, Graduate School of Medicine, Osaka City University
-
- Kozuka Ritsuzo
- Department of Hepatology, Graduate School of Medicine, Osaka City University
-
- Kawamura Etsushi
- Department of Hepatology, Graduate School of Medicine, Osaka City University
-
- Hagihara Atsushi
- Department of Hepatology, Graduate School of Medicine, Osaka City University
-
- Ishizu Hirotaka
- Department of Gastoroenterology, Kashiwara Municipal Hospital
-
- Morikawa Hiroyasu
- Department of Hepatology, Graduate School of Medicine, Osaka City University
-
- Enomoto Masaru
- Department of Hepatology, Graduate School of Medicine, Osaka City University
-
- Murakami Yoshiki
- Department of Hepatology, Graduate School of Medicine, Osaka City University
-
- Tamori Akihiro
- Department of Hepatology, Graduate School of Medicine, Osaka City University
-
- Kawada Norifumi
- Department of Hepatology, Graduate School of Medicine, Osaka City University
Bibliographic Information
- Other Title
-
- ダクラタスビル/アスナプレビル治療が著効したクリオグロブリン血管炎合併C型慢性肝疾患の一例
- 症例報告 ダクラタスビル/アスナプレビル治療が著効したクリオグロブリン血管炎合併C型慢性肝疾患の一例
- ショウレイ ホウコク ダクラタスビル/アスナプレビル チリョウ ガ チョコウシタ クリオグロブリン ケッカンエン ガッペイ Cガタ マンセイ カン シッカン ノ イチレイ
Search this article
Description
<p>A 72-year-old female was diagnosed as having chronic hepatitis C 16 years before, and her anti-viral therapies with interferon were unsuccessful. She suffered from fever, edema and purpura for two months before admission. Then, she was diagnosed with hepatitis C virus-associated mixed cryoglobulinemic vasculitis. After treatment with daclatasvir/asunaprevir, her clinical symptoms improved rapidly and she had a sustained virologic response.</p><p>Since late 2013, several novel DAAs have been approved by the FDA. Interferon-free regimens that combine such novel DAAs are highly effective for the treatment of chronic HCV infection. To our knowledge, this is the first published report documenting the efficacy of daclatasvir/asunaprevir in a patient with HCV-associated mixed cryoglobulinemic vasculitis.</p>
Journal
-
- Kanzo
-
Kanzo 57 (7), 328-333, 2016
The Japan Society of Hepatology
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390001204793698944
-
- NII Article ID
- 130006855880
-
- NII Book ID
- AN00047770
-
- ISSN
- 18813593
- 04514203
-
- NDL BIB ID
- 027496884
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- NDL
- Crossref
- CiNii Articles
-
- Abstract License Flag
- Disallowed
